期刊
EXPERIMENTAL BIOLOGY AND MEDICINE
卷 246, 期 15, 页码 1727-1739出版社
SAGE PUBLICATIONS LTD
DOI: 10.1177/15353702211011052
关键词
Zoledronic acid; osteoporosis; osteoclast; osteoblast; NF-kappa B signaling pathway; RANKL
资金
- Natural Science Foundation of China [82060207]
- Science and Technology Foundation of Guizhou Province [(2016)1124]
Ovariectomy results in bone loss by increasing osteoblast apoptosis and inhibiting osteoclast apoptosis. Zoledronic acid exerts its therapeutic effects in the mandible by counteracting these cellular and molecular effects of ovariectomy.
Bone mass loss (osteoporosis) seen in postmenopausal women is an adverse factor for implant denture. Using an ovariectomized rat model, we studied the mechanism of estrogen-deficiency-caused bone loss and the therapeutic effect of Zoledronic acid. We observed that ovariectomized-caused resorption of bone tissue in the mandible was evident at four weeks and had not fully recovered by 12 weeks post-ovariectomized compared with the sham-operated controls. Further evaluation with a TUNEL assay showed ovariectomized enhanced apoptosis of osteoblasts but inhibited apoptosis of osteoclasts in the mandible. Zoledronic acid given subcutaneously as a single low dose was shown to counteract both of these ovariectomized effects. Immunohistochemical staining showed that ovariectomized induced the protein levels of RANKL and the 65-kD subunit of the NF-kappa B complex mainly in osteoclasts, as confirmed by staining for TRAP, a marker for osteoclasts, whereas zoledronic acid inhibited these inductions. Western blotting showed that the levels of RANKL, p65, as well as the phosphorylated form of p65, and I kappa B-alpha were all higher in the ovariectomized group than in the sham and ovariectomized + zoledronic acid groups at both the 4th- and 12th-week time points in the mandible. These data collectively suggest that ovariectomized causes bone mass loss by enhancing apoptosis of osteoblasts and inhibiting apoptosis of osteoclasts. In osteoclasts, these cellular effects may be achieved by activating RANKL-NF-kappa B signalling. Moreover, zoledronic acid elicits its therapeutic effects in the mandible by counteracting these cellular and molecular consequences of ovariectomized.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据